Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis.

Journal article

Avgerinos I. et al, (2021), Diabetes Obes Metab

Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis.

Journal article

Avgerinos I. et al, (2021), Diabetes Obes Metab

Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes.

Journal article

Tsapas A. et al, (2021), Ann Intern Med, 174

Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program.

Journal article

Matthews DR. et al, (2020), Diabetes Obes Metab, 22, 2199 - 2203

Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.

Journal article

Katulanda P. et al, (2020), Diabetologia, 63, 1440 - 1452

Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.

Journal article

Katulanda P. et al, (2020), Diabetologia, 1 - 13

ADVANCE.

Journal article

Matthews DR., (2020), Diabetes Obes Metab, 22 Suppl 2, 3 - 4

Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis.

Journal article

Avgerinos I. et al, (2020), Diabetes Obes Metab, 22, 335 - 345

Among young Sri Lankan patients with diabetes, how do lipid profiles differ between those with and without metabolic syndrome?

Journal article

Katulanda GW. et al, (2019), Diabetes Metab Syndr, 13, 3057 - 3063

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program.

Journal article

Matthews DR. et al, (2019), Diabetologia, 62, 926 - 938

Load More